Figure 4.

The distribution of drug-sensitivity-correlated IA probes. (A) The number of IA probes with significant (P <0.05) gene-drug correlation with each anti-cancer compound is plotted according to the grouping of the drug mechanism. The dotted line gives the mean of the probe counts in each group. (B) The numbers of significant IA probes in tubulin-binding agents and targeted therapy agents.

Hsu et al. BMC Medicine 2013 11:106   doi:10.1186/1741-7015-11-106
Download authors' original image